Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Redactive | 2024 | Seed | $7.7M | Melbourne |
| Redactive AI | 2024 | Seed | $7.2M | Melbourne |
| Recursion Pharmaceuticals | 2024 | Post Ipo Equity | $200.0M | Salt Lake City |
| Formation Bio | 2024 | Series D | $372.0M | New York |
| Cruise | 2024 | Corporate Round | $850.0M | San Francisco |
| Avidbots Corp. | 2024 | Series D | Undisclosed | Kitchener |
| LabGenius | 2024 | Series B | $44.5M | London |
| Sona | 2024 | Series A | $27.5M | London |
| DatologyAI | 2024 | Series A | $46.0M | Redwood City |
| Edia Learning | 2024 | Series A | $9.4M | New York |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 251 | Redactive | Seed | $7.7M | Melbourne, Australia |
| 252 | Redactive AI | Seed | $7.2M | Melbourne, Australia |
| 253 | Recursion Pharmaceuticals | Post Ipo Equity | $200.0M | Salt Lake City, United States |
| 254 | Formation Bio | Series D | $372.0M | New York, United States |
| 255 | Cruise | Corporate Round | $850.0M | San Francisco, United States |
| 256 | Avidbots Corp. | Series D | Undisclosed | Kitchener, Canada |
| 257 | LabGenius | Series B | $44.5M | London, United Kingdom |
| 258 | Sona | Series A | $27.5M | London, United Kingdom |
| 259 | DatologyAI | Series A | $46.0M | Redwood City, United States |
| 260 | Edia Learning | Series A | $9.4M | New York, United States |
Redactive provides secure and scalable pipelines for AI application developers, enabling real-time retrieval of business data.
Redactive provides secure and scalable pipelines for AI application developers, enabling real-time retrieval of business data.
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
Cruise is an autonomous vehicle company that develops electric cars for urban mobility.
Avidbots designs, manufactures, sells and supports autonomous connected robots that expand human potential.
LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
Sona is a workforce management platform for frontline enterprises like care homes, restaurants, and hotels.
DatologyAI is an AI-data curation startup that develops deep learning tools for automatic selection in data training.
Edia is an EdTech platform for 6-12 Math that ensures superior state test outcomes.
Hailo develops AI processors specifically designed to enable AI tasks on the edge.
Key AI helps communities to reach their full potential.
Brevian is a sales intelligence platform that transforms sales process and help close deals faster and more effectively.
Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.
Flower is a federated learning, analytics, and evaluation platform.
Motif Analytics is a data analytics startup that developed a data exploration platform.
Reservoir Neuroscience is a biopharma company that develops novel therapeutics.
Zubale develops business management software to connect brands and retailers.
Puzzle Financial is a modern data platform for startups
Zenreach connects your online marketing with in-store results for digital marketing that performs 4x better.
Modern operating system for aging & disability service providers
MotherDuck provides data infrastructure and analytics for both small and big data.
ThirdLove is a women’s lifestyle brand that offers a range of lingerie and underwear.
The collaborative Enterprise platform to build AI Agents.
Ask anything about your patients. Automate what happens next.
Felicis has invested in 382 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Felicis's top investment sectors include Artificial Intelligence (AI), Software, Machine Learning, Biotechnology, Therapeutics. The firm invests across 60 different industry categories.
Among tracked funding rounds, Cruise received $850.0M in a Corporate Round round. Felicis's total known invested capital is $13.2B.
Felicis's average investment size is $54.5M across its portfolio of 382 companies.
Recent Felicis portfolio additions include Redactive, Redactive AI, Recursion Pharmaceuticals, Formation Bio, Cruise. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors